Journal of experimental orthopaedics · 2026
Comparison of patellofemoral osteoarthritis between patients treated surgically or non-surgically following anterior cruciate ligament injuries: A systematic review and meta-analysis.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Franco Domenico, Bumberger Alexander, Schmidt Sebastian, Leite Chilan B G, Russo Fabrizio, Vadalà Gianluca, Papalia Rocco, Denaro Vincenzo, Jacobs Cale, Lattermann Christian
Аннотация
PURPOSE: We hypothesized that patients undergoing anterior cruciate ligament reconstruction (ACL-R) are more likely to develop patellofemoral osteoarthritis (PFOA) than those with an ACL injury managed non-surgically.
STUDY DESIGN: Systematic review and Meta-analysis.
METHODS: A systematic literature review and meta-analysis were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Studies reporting PFOA assessment by radiographic or magnetic resonance imaging after ACL-R compared to non-surgical treatment of ACL injury were included. Studies involving individuals with concurrent other ligamentous or chondral injuries treated surgically were excluded to minimize bias.
RESULTS: A total of six studies were included in the systematic review. The meta-analysis demonstrated that patients undergoing ACL-R had a significantly higher likelihood of developing PFOA compared to those who received non-surgical treatment after ACL injury (odds ratio [OR] = 2.21; 95% confidence interval [CI]: 1.13-4.35; p = 0.02). Patients who underwent ACL-R with bone-patellar tendon-bone (BPTB) autograft exhibited a significantly higher prevalence of PFOA than those with HT autograft (p < 0.01). Moreover, male patients exhibited a higher association with PFOA than females in both the ACL-R (34.38% vs. 7.77%, p < 0.001) and non-surgical ACL injury groups (28.13% vs. 0.97%, p < 0.001).
CONCLUSIONS: ACL-R significantly increases the likelihood of PFOA compared to non-surgical ACL treatment, especially when using BPTB autografts. Male patients demonstrated a higher association with PFOA in both groups. Targeted preventive strategies, including optimized graft selection and enhanced rehabilitation protocols, are crucial for reducing the risk of PFOA following ACL-R.
LEVEL OF EVIDENCE: Level III.
STUDY DESIGN: Systematic review and Meta-analysis.
METHODS: A systematic literature review and meta-analysis were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Studies reporting PFOA assessment by radiographic or magnetic resonance imaging after ACL-R compared to non-surgical treatment of ACL injury were included. Studies involving individuals with concurrent other ligamentous or chondral injuries treated surgically were excluded to minimize bias.
RESULTS: A total of six studies were included in the systematic review. The meta-analysis demonstrated that patients undergoing ACL-R had a significantly higher likelihood of developing PFOA compared to those who received non-surgical treatment after ACL injury (odds ratio [OR] = 2.21; 95% confidence interval [CI]: 1.13-4.35; p = 0.02). Patients who underwent ACL-R with bone-patellar tendon-bone (BPTB) autograft exhibited a significantly higher prevalence of PFOA than those with HT autograft (p < 0.01). Moreover, male patients exhibited a higher association with PFOA than females in both the ACL-R (34.38% vs. 7.77%, p < 0.001) and non-surgical ACL injury groups (28.13% vs. 0.97%, p < 0.001).
CONCLUSIONS: ACL-R significantly increases the likelihood of PFOA compared to non-surgical ACL treatment, especially when using BPTB autografts. Male patients demonstrated a higher association with PFOA in both groups. Targeted preventive strategies, including optimized graft selection and enhanced rehabilitation protocols, are crucial for reducing the risk of PFOA following ACL-R.
LEVEL OF EVIDENCE: Level III.